SCHEMBL8216635

SCHEMBL8216635

CCN(CC)CC.Cc1ccc2[nH]c(-c3ccccc3)c(CCC(=O)O)c2c1

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.64
KDM4E B2RXH2 2/20 0.64
ALDH1A1 P00352 2/20 0.64
GFER P55789 2/20 0.64
PPARG P37231 5/20 0.58
EGFR P00533 1/20 0.57
HTR2A P28223 1/20 0.54
HTR2C P28335 1/20 0.54
TACR1 P25103 2/20 0.54
CYP1A2 P05177 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
PIM1 P11309 1/20 0.48
MEN1 O00255 1/20 0.48
HTT P42858 1/20 0.48
KMT2A Q03164 1/20 0.48
HSD17B10 Q99714 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6922498 0.93 PPARG (0.66) HPGDKDM4EALDH1A1GFERPPARG
SCHEMBL7242395 0.87 PPARG (0.61) HPGDKDM4EALDH1A1GFERPPARG
SCHEMBL31006355 0.82 EGFR (0.60) KDM4EALDH1A1PPARGEGFRTACR1
SCHEMBL22118483 0.82 EGFR (0.60) KDM4EALDH1A1PPARGEGFRTACR1
SCHEMBL6929315 0.81 KDM4E (0.69) HPGDKDM4EALDH1A1GFERPPARG
SCHEMBL4814649 0.80 PPARG (0.67) HPGDKDM4EALDH1A1GFERPPARG
SCHEMBL7238606 0.80 PPARG (0.55) HPGDKDM4EALDH1A1GFERPPARG
SCHEMBL6926495 0.79 PPARG (0.60) HPGDKDM4EALDH1A1PPARGEGFR
SCHEMBL6624875 0.79 KDM4E (0.68) KDM4EALDH1A1PPARGEGFRHTR2A
SCHEMBL6929600 0.78 PPARG (0.66) KDM4EALDH1A1PPARGEGFRTACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000051984-A1 2-ARYL INDOLE DERIVATIVES AS ANTAGONISTS OF TACHYKININS MERCK SHARP & DOHME LIMITED (GB) 2000-09-08 WO disclosed